Gilbert Thiel
ATG-Fresenius or daclizumab induction therapy in immunologically high risk kidney recipients: a prospective randomized pilot trial
Kim M, Tsinalis D, Franz S, Binet F, Gürke L, Mihatsch M, Steiger J, Thiel G, Dickenmann M. ATG-Fresenius or daclizumab induction therapy in immunologically high risk kidney recipients: a prospective randomized pilot trial. Annals of transplantation : quarterly of the Polish Transplantation Society 2008; 13:21-7.
01.01.2008ATG-Fresenius or daclizumab induction therapy in immunologically high risk kidney recipients: a prospective randomized pilot trial
01.01.2008Annals of transplantation : quarterly of the Polish Transplantation Society 2008; 13:21-7
Kim Min Jeong, Tsinalis Dimitrios, Franz Stefan, Binet Françoise-Isabelle, Gürke Lorenz, Mihatsch Michael J, Steiger Jürg, Thiel Gilbert, Dickenmann Michael
Why do kidney grafts fail?A long-term single-center experience
Dickenmann M, Nickeleit V, Tsinalis D, Gürke L, Mihatsch M, Thiel G. Why do kidney grafts fail?A long-term single-center experience. Transplant international : official journal of the European Society for Organ Transplantation 2002; 15:508-14.
01.10.2002Why do kidney grafts fail?A long-term single-center experience
01.10.2002Transplant international : official journal of the European Society for Organ Transplantation 2002; 15:508-14
Dickenmann Michael J, Nickeleit Volker, Tsinalis Dimitrios, Gürke Lorenz, Mihatsch Michael J, Thiel Gilbert